Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-28

FDA Approved: NABUMETONE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Nabumetone submitted by Actavis Pharma, Inc., relating to Nabumetone's approval status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nabumetone (Nabumetone)

Snippet

SUPPL AP for NABUMETONE (NABUMETONE)